USPTO Patents Application 09993647

EFSID:

7718064

Application Number:

09993647

International Application Number:

Confirmation Number:

1010

Title of Invention:

omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors

First Named Inventor/Applicant Name:

Bernd Riedl

Customer Number:

23599

Filer:

Csaba Henter/Caitlin Sickler

Filer Authorized By:

Csaba Henter

Attorney Docket Number:

BAYER ISA

Receipt Date:

Ol-JUN-2010

Filing Date:

27-NOV-2001

Time Stamp:

13:31:18

Application Type:

Utility under 35 USC 111(a)

Payment information:

Submitted with Payment

no

File Listing:

Document
Number

Document Description

File Name

FileSize(Bytes)/
Message Digest

Multi
Part /.zip

Pages
(if appl.)

1

NPL Documents

P32-

CampbelllncreasingComplexity
ofRasSignaling.pdf

2424350

a9005795 d543aa40f07cec14e63d4b28e97
1cd17

no

19

Warnings:

Information:

2

NPL Documents

P33-CANCER-WEEKLY.pdf

140661

no

1

3232e036f48ae77031 2cdd40a1 2c4cc85e8c
3833

Warnings:

Information:

3

NPL Documents

P34-CanettaCarboplatin-
CurrentStatusAndFutureProspe
cts.pdf

3826172

no

45

68cb8b378f1b057d3ed83f5db47e22ebc35
6dddb

Warnings:

Information:

4

NPL Documents

P34a-

CaponigroetalEpidermalGrowt
hFactor.PDF

1083691

no

12

Cb0da2475eb186592ee47a8decbd95aadd
78f602

Warnings:

Information:

5

NPL Documents

P35-

CareyetalPartAStructureandMe
chanisims.pdf

471534

no

12

e37a47031 d1f732b526971 72521 055ce78a
92583

Warnings:

Information:

6

NPL Documents

P36-Carlingetan-3-
Cyanobenzylpiperidin-4-yl-5-
methyl-4-phenyl-l-3.pdf

1040304

no

10

0bbeed7391a54a281fa7114b24c8446f06e
599bc

Warnings:

Information:

7

NPL Documents

P37-

CARLOMAGNOETALIngibitionO
nconogenicRET.pdf

1069541

no

9

4ad37714335cf38ca3ad2d3693398db4c80
c33d

Warnings:

Information:

8

NPL Documents

P37a-

CarneyetalClinicalBreastCancer.
pdf

1138273

no

12

5c6566aff1 2dd1 C0b8c0259f5580f68e06b5
2364

Warnings:

Information:

9

NPL Documents

P38-

CarteretalAntitumorEfficacy.pdf

167798

no

1

7c2cec57211e6d7473851930bcb3a329f1c
591dc

Warnings:

Information:

10

NPL Documents

P39-CARTER-ET-AL-
ChemotherapyofCancer.pdf

136044

no

3

5a19a450599c3aaa0245938a96f4db2087c
09231

Warnings:

Information:

11

NPL Documents

P40-CARTERETAL-
SorefenibNonSmallCellLung.
pdf

169623

no

2

f5ae266e2e27265c039079605b12c8ae22d
2566a

Warnings:

Information:

12

NPL Documents

P41-

ChangBAY43-9006Sorafeniblnh
ibitsEctopicSCandOrthotopicGr
owthofaMurine.pdf

73262

no

1

b459963e6d62393827dc61 063921 21 3bbd
2088f2

Warnings:

Information:

13

NPL Documents

P42-

ChangetalSorafeniblnhibitsTu
morGrowth.pdf

1922377

no

14

831604d6f312d7c6609a9fc5d26ec8393a43
1a9c

Warnings:

Information:

14

NPL Documents

P43-

ChenetalRoleofRegulatoryElem
ents.pdf

1457296

no

13

ac3054b2e2e0bc696c60ac5a80580ef4c186
f8ee

Warnings:

Information:

15

NPL Documents

P44-

ChenetalSuppresionofJapanese
Encephalitis.pdf

847967

no

9

bb6ae1b3ba6d270c849107bb032289078ff
6406b

Warnings:

Information:

16

NPL Documents

P44a-Chen-et-al-Clin-Cancer-
Res-v5-n6-pl369.pdf

5134664

no

11

fd2f7fc86a01f75334ebf09ade25f5c2bb96a
8c 1

Warnings:

Information:

17

NPL Documents

P45-Chialdaetal-
RespiratoryResearch.pdf

1531043

no

19

7ea2793b91 8dd0ad1 34a01 368ded001 OffS
45ac9

Warnings:

Information:

18

NPL Documents

P45a-Chin-et-al-Eur-J-Surg-
Oncol-v29-p497.pdf

495783

no

9

adef33c0baed130c2e29c0972bcd524ea14
705ee

Warnings:

Information:

19

NPL Documents

P46-CHOI-lmatinib-
ResistantCellLinesareSensitivet
otheRAFInhibitorBAY.pdf

285856

no

1

Ce5d 049ac10d061f9da655ce2af58f2fa4048
10b

Warnings:

Information:

20

NPL Documents

P46a-

ChoongetalForthcomingRecep
torTyrosineKinase.PDF

442002

54975ac2758bf361 df9e881 1 de8d4d0ccbb
el 562

no

5

Warnings:

Information:

Total Files Size (in bytes)

23858241

This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents,
characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
Post Card, as described in MPEP 503.

New Applications Under 35 U.S.C. 1 1 1

If a new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
1 .53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1 .54) will be issued in due course and the date shown on this
Acknowledgement Receipt will establish the filing date of the application.

National Stage of an International Application under 35 U.S.C. 371

If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903 indicating acceptance of the application as a
national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.

New International Application Filed with the USPTO as a Receiving Office

If a new international application is being filed and the international application includes the necessary components for
an international filing date (see PCT Article 1 1 and MPEP 1 81 0), a Notification of the International Application Number
and of the International Filing Date (Form PCT/RO/105) will be issued in due course, subject to prescriptions concerning
national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
the application.